The Familial Cancer Predisposition Working Group has been convened to focus on TP53 mutation carriage and the development of consistent advice on how this should be managed in the New Zealand child cancer population.
The Familial Cancer Predisposition Working Group has been convened to focus on TP53 mutation carriage and the development of consistent advice on how this should be managed in the New Zealand child cancer population.
The objectives of the group include:
For more information contact
Scott Macfarlane
Familial Cancer Predisposition Working Group Convenor
scottm@adhb.govt.nz